封面
市場調查報告書
商品編碼
2077690

心臟植入式電子設備市場:按類型、最終用戶和地區分類

Cardiac Implantable Electronic Device Market, By Type, By End User, and By Region

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,心臟植入式電子設備市場規模將達到352.6億美元,2033年將達到604.3億美元。預計從2026年到2033年,該市場將以8.0%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 352.6億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 8.00% 2033年市場規模預測: 604.3億美元

心臟植入是植入心臟組織以控制心律不整的醫療設備。市面上已有多種心臟植入式心臟整流去顫器、植入式心臟復律去顫器 (ICD) 和心率植入,用於治療心率、心律不整等心臟功能障礙和其他心臟相關疾病。這些心臟植入主要用於治療心臟衰竭患者。近年來,心臟植入融合了多項創新技術,顯著提高了心臟衰竭患者的生活品質。心臟心律調節器植入術是將一個小型電子設備植入體內,通常位於胸部(鎖骨下方),以調節心臟電脈衝的延遲。醫生可能會建議使用心臟節律器來防止心率降至危險的低水平。心臟節律器分為三種類型:單心室心律調節器將一根導線連接到心臟的上心室或下心室;雙心室心律調節器使用兩根導線,一根連接到上心室,另一根連接到下心室;雙心室心律調節器用於心臟再同步治療。植入式心臟整流去顫器(ICD) 是一種小型電池供電裝置,植入胸部,用於檢測和終止心律不整。 ICD 持續監測心率,並在需要時釋放電擊以恢復正常心率。預計在預測期內,心律不整發病率的上升、人口老化和人口結構變化將推動全球心臟植入式電子設備市場的成長。

市場動態

心血管疾病(如心律不整和冠狀動脈疾病)的日益普遍,以及人口老化和人口結構變化,預計將在預測期內推動全球心臟植入式電子設備市場的成長。例如,根據美國疾病管制與預防中心(CDC)的數據,截至2023年5月15日,2021年美國約有69.5萬人死於心臟病,佔所有死亡人數的五分之一;約有二十分之一的20歲及以上成年人患有冠狀動脈疾病(CAD)。

本研究的主要特點:

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數,對全球心臟植入式電子產品市場的主要公司進行了概況介紹:公司概況、產品系列、主要亮點、財務績效和策略。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
  • 全球心臟植入式電子設備市場報告的目標受群眾外包括該行業的各類相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過對全球心臟植入式電子設備市場進行分析時所使用的各種策略矩陣,相關人員將能夠做出更順利的決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場吸引力分析
    • 市場機遇
    • 併購和合作
    • 資金籌措及投資
    • 監管準則和合規性
    • 主要進展
    • PEST分析
    • 波特的分析

第4章 全球心臟植入式電子設備市場:依類型分類,2021-2033年

  • 植入式心臟節律器
  • 體外心律調節器

第5章 全球心臟植入式電子設備市場:依最終用戶分類,2021-2033年

  • 醫院
  • 專科診所
  • 門診部

第6章 全球心臟植入式電子設備市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第7章 競爭情勢

  • Medtronic
  • Biotronik
  • Boston Scientific Corporation or its affiliates
  • Pacetronix.com
  • Integer Holdings Corporation
  • Cook Group
  • Braile Biomedica
  • Abbott
  • LivaNova PLC
  • OSYPKA Medical
  • Galix Biomedical Instrumentation Inc.
  • OSCOR Inc.
  • LifeTech Scientific Corporation
  • MicroPort Scientific Corporation
  • Ceryx Medical

第8章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI3949

Cardiac Implantable Electronic Device Market is estimated to be valued at USD 35.26 Bn in 2026 and is expected to reach USD 60.43 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.0% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 35.26 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 8.00% 2033 Value Projection: USD 60.43 Bn

Cardiac implants are devices that are implanted in the heart tissue, in order to control irregular heart function. Cardiac implants such as pacemakers, defibrillator implants, and cardiac rhythm monitoring implants are available in the market to treat cardiac dysfunction such as heart rhythm disorders, arrhythmias, and other heart related disorders. These cardiac implants are majorly prescribed to patients with heart failure. Cardiac implants have been developed with innovative technical features in the recent years, and this has improved quality of life of patients with heart failure. A pacemaker insertion is the implantation of a small electronic device that is usually placed in the chest (just below the collarbone) to regulate slow electrical problems related to heart. A pacemaker can be recommended to ensure that the heartbeat does not slow to a dangerously low rate. There are three kind of pacemakers: single chamber- one lead attaches to the upper or lower heart chamber, dual-chamber- it uses two leads, one for the upper and one for the lower chamber, and biventricular pacemakers that is used in cardiac resynchronization therapy. An implantable cardioverter-defibrillator (ICD) is a small battery-powered device that is placed in the chest to detect, and to stop irregular heartbeats (arrhythmias). An ICD continuously monitors the heartbeat and delivers electric shocks, when needed, to restore a regular heart rhythm. Increasing incidence of cardiac arrhythmia, aging population, and demographic changes are expected to drive the global cardiac implantable electronic device market growth over the forecast period.

Market Dynamics

Increasing prevalence of cardiovascular diseases such as cardiac arrhythmia, coronary artery disease, and others, aging population, and demographic changes are expected to drive the global cardiac implantable electronic device market growth over the forecast period. For instance, on May 15, 2023, according to the Centers for Disease Control and Prevention, in the U.S., heart disease caused around 695,000 deaths in 2021, accounting for 1 in every 5 fatalities and around 1 in 20 adults aged 20 and older have coronary artery disease (CAD).

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cardiac implantable electronic device market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study are Medtronic, Biotronik, Boston Scientific Corporation or its affiliates, Pacetronix.com, Integer Holdings Corporation, Cook Group, Braile Biomedica, Abbott, LivaNova PLC, OSYPKA Medical, Galix Biomedical Instrumentation Inc., OSCOR Inc., LifeTech Scientific Corporation, MicroPort Scientific Corporation, and Ceryx Medical
  • Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global cardiac implantable electronic device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac implantable electronic device market

Detailed Segmentation:

  • Global Cardiac Implantable Electronic Device Market, By Type (Revenue, USD Bn, 2021 - 2033)
  • Implantable Pacemakers
  • External Pacemakers
  • Global Cardiac Implantable Electronic Device Market By End User:
  • Hospitals
  • Specialty Clinics
  • Ambulatory Care Settings
  • Global Cardiac Implantable Electronic Device Market, By Region (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
  • Medtronic
  • Biotronik
  • Boston Scientific Corporation or its affiliates
  • Pacetronix.com
  • Integer Holdings Corporation
  • Cook Group
  • Braile Biomedica
  • Abbott
  • LivaNova PLC
  • OSYPKA Medical
  • Galix Biomedical Instrumentation Inc.
  • OSCOR Inc.
  • LifeTech Scientific Corporation
  • MicroPort Scientific Corporation
  • Ceryx Medical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Attractiveness Analysis
    • Market Opportunities
    • Merger, Acquisition, and Collaborations
    • Funding and Investment
    • Regulatory Guideline and Compliances
    • Key Developments
    • PEST Analysis
    • PORTER's Analysis

4. Global Cardiac Implantable Electronic Device Market, By Type, 2021 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Implantable Pacemakers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
  • External Pacemakers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

5. Global Cardiac Implantable Electronic Device Market, By End User, 2021 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segments Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
  • Ambulatory Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

6. Global Cardiac Implantable Electronic Device Market, By Region, 2021 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2022-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Billion)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Biotronik
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boston Scientific Corporation or its affiliates
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pacetronix.com
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Integer Holdings Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cook Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Braile Biomedica
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LivaNova PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • OSYPKA Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Galix Biomedical Instrumentation Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • OSCOR Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LifeTech Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • MicroPort Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ceryx Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

8. Section

  • Research Methodology
  • About Us